TCL Archive ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention January 10, 1997
TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets October 25, 2002